| Date Filed | Type | Description |
| 08/17/2023 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 11,480 options to buy
@ $7, valued at
$80.4k
|
|
| 01/23/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2023 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 46 shares
@ $0
Granted 2,342 options
@ $55.23, valued at
$129.3k
Granted 2,342 options
@ $8.7, valued at
$20.4k
|
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2022 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Paid exercise price by delivering 3,562 shares
@ $7.51, valued at
$26.8k
Exercised 8,333 options to buy
@ $3.21, valued at
$26.7k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
5
| SIDRANSKY DAVID (Director) has filed a Form 5 on Orgenesis Inc. |
| 11/09/2021 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 8,045 options to buy
@ $10.1, valued at
$81.3k
|
|
| 11/04/2021 |
3
| SIDRANSKY DAVID (Director) has filed a Form 3 on Cactus Acquisition Corp. 1 Ltd |
| 10/19/2021 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Exercised 16,667 shares
@ $1.59, valued at
$26.5k
Paid exercise price by delivering 2,629 shares
@ $10.08, valued at
$26.5k
Granted 16,667 options to buy
@ $1.59, valued at
$26.5k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Bought 200 shares
@ $15.27, valued at
$3.1k
Bought 25 shares
@ $15.02, valued at
$375.5
Bought 1 shares
@ $9.6, valued at
$9.6
Bought 4 shares
@ $11.86, valued at
$47.4
Bought 5 shares
@ $11.07, valued at
$55.4
Bought 10 shares
@ $10.07, valued at
$100.7
Bought 1 shares
@ $10.7, valued at
$10.7
Bought 4 shares
@ $11.56, valued at
$46.2 |
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 8,333 options to buy
@ $11.96, valued at
$99.7k
|
|
| 10/28/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Paid exercise price by delivering 10,100 shares
@ $9.01, valued at
$91k
Exercised 16,667 options to buy
@ $5.46, valued at
$91k
|
|
| 05/07/2020 |
3
| SIDRANSKY DAVID (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
| 05/05/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 13,000 options
@ $0.66, valued at
$8.6k
|
|
| 03/20/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Orgenesis Inc.|
Txns:
| Granted 12,500 options
@ $2.99, valued at
$37.4k
|
|
| 01/16/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Orgenesis Inc.|
Txns:
| Granted 12,500 options
@ $2.99, valued at
$37.4k
|
|
| 11/06/2019 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 8,333 options to buy
@ $5.43, valued at
$45.2k
|
|
| 10/25/2019 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 10,000 options
@ $0.31, valued at
$3.1k
|
|
| 03/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 30,000 options
@ $0.54, valued at
$16.2k
|
|
| 11/05/2018 |
4/A
| SIDRANSKY DAVID (Director) has filed a Form 4 on Orgenesis Inc.|
Txns:
| Granted 29,200 options
@ $5.99, valued at
$174.9k
|
|
| 11/05/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 8,333 options to buy
@ $12.73, valued at
$106.1k
|
|
| 10/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/27/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 06/14/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 5,000 shares
@ $1.71, valued at
$8.6k
|
|
| 06/13/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 3,198 shares
@ $1.85, valued at
$5.9k
Granted 6,802 shares
@ $1.84, valued at
$12.5k
|
|
| 11/06/2017 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 30,000 options
@ $3.19, valued at
$95.7k
|
|
| 11/03/2016 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.|
Txns:
| Granted 16,667 options
@ $1.59, valued at
$26.5k
|
|
| 08/10/2016 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Sold 11,404 shares
@ $15.17, valued at
$173k
Sold 11,404 shares
@ $14.85, valued at
$169.3k
|
|
|